PROSPER: A phase 3 study of enzalutamide (ENZA) in men with non-metastatic castration-resistant prostate cancer (nmCRPC)B. Tombal,M. Hussain,K. Fizazi,F. Saad,P. Rathenborg,N. D. Shore,E. Demirhan,K. Modelska,D. Phung,A. Krivoshik,C. N. SternbergSWISS MEDICAL WEEKLY(2018)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要